What: Biosite(R) Incorporated will host its 2nd Annual Research
and Development Conference, The Power of Panels, on Tuesday,
October 11, 2005, beginning at 11:00 AM Eastern Standard
Time.
This year's program will be moderated by Dr. Norman Paradis,
Biosite's vice president of medical affairs, and will
feature presentations relating to diagnostic challenges
affecting today's acute care providers and the potential for
improving patient outcomes through the use of rapid protein
biomarker-based diagnostics. Company management will also
discuss Biosite's ongoing and potential research programs
and product portfolio strategy. Biosite's current
development projects include, but are not limited to,
potential tests to aid in the diagnosis of acute coronary
syndromes, stroke, sepsis and abdominal pain.
Featured presenters include: Daniel Laskowitz, M.D., Duke
University Medical Center, Durham; Peter McCullough, M.D.,
Beaumont Health Center, Royal Oak, Mich.; John Pettini,
M.D., University of Texas Medical Center, Dallas; Stephen
Gormican, M.D., Scripps Memorial Hospital, La Jolla, Calif.;
Joseph Feldman, M.D., Hackensack University Medical Center,
Hackensack, New Jersey; and Charles Lowenstein, M.D., Johns
Hopkins Medical Center, Baltimore.
How: The Company will webcast the conference on the same day
(Tuesday, October 11th) from 11:00 AM Eastern Standard Time
until 5:00 PM Eastern Standard Time. Simply log onto the web
at the address below:
http://www.corporate-ir.net/media_files/webcast/2005/oct/bste/agenda.htm
OR http://www.biosite.com
If you are unable to participate during the live webcast, the conference
will be archived on the Biosite web site http://www.biosite.com until November 10,
2005 at 2:30 p.m.
Contact: Simona Dixon
Corporate and Investor Relations
Biosite Incorporated
(858) 805-2824
email: sdixon@biosite.com
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of
U.S. hospitals and in more than 50 international markets. Information on
Biosite can be found at http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations, +1-858-805-2820, npadilla@biosite.com, or
Nicole Beckstrand, +1-858-401-2897, nbeckstrand@biosite.com, both
of Biosite Incorporated
|
